Vivalyx is dedicated to solve the global organ shortage. It costs millions of lives and billions of dollars and is solvable by perfusing organs at body temperature: a method clinically proven but hardly scalable due to reliance on rare donor blood and its extreme costs. Vivalyx introduces a patented solution surpassing this barrier for the first time, making perfusion at body temperature scalable. The Vivalyx technology triples the efficacy of the blood-based benchmark in preclinical trials, is fully synthetic—eliminating blood-related concerns.

‍